The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation
Abstract
Lactic acidosis is common to most solid tumors and has been found to affect infiltrating immune cells. Here we document effector phase inhibition of cytotoxic T cells (CTLs) involving complete blockage of cytokine production and partial impairment of lytic granule exocytosis. Lactic acidosis impaired TCR‐triggered phosphorylation of JNK, c‐Jun and p38, while not affecting MEK1 and ERK. The select targeting of signaling proteins involved in IFNγ production (JNK/c‐Jun, p38) without affecting those jointly used in cytokine regulation and granule exocytosis (MEK1/ERK) explains the observed split effect of lactic acidosis on the CTL responses. CTL inhibition by lactic acidosis showed fast dynamics with immediate onset and reversion. Functional recovery by neutralizing the extracellular pH despite continuous presence of lactate holds promise that CTL activity can be improved in the milieu of solid tumors with appropriate anti‐acidosis treatment, thereby increasing the efficacy of adoptive T cell therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Self-citationThe proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430281 · Cited by 1,348
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3
Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., & Crabtree, G. R. (1997) · Science · doi:10.1126/science.275.5308.1930 · Cited by 754
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
Robey, I. F., Baggett, B. K., Kirkpatrick, N. D., Roe, D. J., Dosescu, J., Sloane, B. F., Hashim, A. I., Morse, D. L., Raghunand, N., Gatenby, R. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-5575 · Cited by 661
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Rosenberg, S. A., & Dudley, M. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.03.002 · Cited by 595
Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules
de Saint Basile, G., Ménasché, G., & Fischer, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2803 · Cited by 446
Immune resistance orchestrated by the tumor microenvironment
Gajewski, T. F., Meng, Y., Blank, C., Brown, I., Kacha, A., Kline, J., & Harlin, H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00442.x · Cited by 437
Regulation of the immune response by stress‐activated protein kinases
Rincón, M., & Davis, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00744.x · Cited by 266
The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
Chen, J. L.-Y., Lucas, J. E., Schroeder, T., Mori, S., Wu, J., Nevins, J., Dewhirst, M., West, M., & Chi, J.-T. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000293 · Cited by 213
Silva, A. S., Yunes, J. A., Gillies, R. J., & Gatenby, R. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2394 · Cited by 205
Schendel, D. J., Gänsbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A. G., Riethmüller, G., & Segurado, O. G. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4209 · Cited by 157
The T-cell-receptor signaling network
Huse, M. (2009) · Journal of Cell Science · doi:10.1242/jcs.042762 · Cited by 156
Tumor-induced modulation of dendritic cell function
Gottfried, E., Kreutz, M. P., & Mackensen, A. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.008 · Cited by 122
Self-citationTeixeira, L. K., Fonseca, B. D. P. F. E., Vieira‐de‐Abreu, A., Barboza, B. A., Robbs, B. K., Bozza, P. T., & Viola, J. P. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5931 · Cited by 88
Extracellular Acidification Elicits Spatially and Temporally Distinct Ca2+ Signals
Huang, W., Swietach, P., Vaughan‐Jones, R. D., Ansorge, O., & Glitsch, M. D. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.049 · Cited by 85
T cells targeted against a single minor histocompatibility antigen can cure solid tumors
Meunier, M., Delisle, J., Bergeron, J., Rineau, V., Baron, C., & Perreault, C. (2005) · Nature Medicine · doi:10.1038/nm1311 · Cited by 80
Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response
Frey, A. B., & Monu, N. R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105628 · Cited by 74
Loss of CTL Function among High-Avidity Tumor-Specific CD8+ T Cells following Tumor Infiltration
Janicki, C. N., Jenkinson, S. R., Williams, N., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5008 · Cited by 72
Lack of Effector Cell Function and Altered Tetramer Binding of Tumor-Infiltrating Lymphocytes
Blohm, U., Roth, E., Brommer, K., Dumrese, T., Rosenthal, F. M., & Pircher, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5522 · Cited by 66
Imai, N., Ikeda, H., Tawara, I., & Shiku, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838824 · Cited by 52
Immune suppression in renal cell carcinoma
Frankenberger, B., Noeßner, E., & Schendel, D. J. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.004 · Cited by 41
T-Cell Receptor Signaling Events Triggering Granule Exocytosis
Radoja, S., Frey, A. B., & Vukmanović, S. (2006) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v26.i3.40 · Cited by 37
Leisegang, M., Turqueti‐Neves, A., Engels, B., Blankenstein, T. J. F., Schendel, D. J., Uckert, W., & Noeßner, E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2897 · Cited by 36
[On the facultative anaerobiosis of cancer cells and its use in chemotherapy].
Warburg, O. H. (1961) · PubMed · Cited by 29
Cited by
Lactate metabolism in human health and disease
Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J.-X., Wang, Z., & Yu, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01151-3 · Cited by 1,454
Targeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,166
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Bader, J. E., Voss, K., & Rathmell, J. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.034 · Cited by 1,030
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Metadata
- Authors
- Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M., Gottfried, E., & Noessner, E.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-10-05
- Volume
- 131
- Issue
- 3
- Pages
- 633-640
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2035566116
- Cited by
- 319
- References
- 27
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.